iShares Nasdaq Biotechnology ETF

Find Ratings Reports
IBB : NASDAQ : Financial
$320.74 | %
Today's Range: 316.12 - 321.27
Avg. Daily Volume: 1002200.0
06/23/17 - 4:00 PM ET

PEER GROUP ANALYSIS

IBB Peer Plot Chart

This chart compares IBB to the highest rated funds in its peer group of Sector - Health/Biotechnology funds. The above graph illustrates two key measures that investors should consider when assessing the investment potential of a particular fund. One of the key factors is how the fund has performed over the most recent reporting period, defined as the 1 year total return on the bottom axis. The second factor is the fund's reported expense ratio, on the right axis, which includes things like management fees. The best funds, with higher returns and lower expenses, stake out a position in the lower left part of this graph.


TOP RATED FUNDS : Sector - Health/Biotechnology
NameTickerReturn
YTD
1 Year
Return
3 Year
Return
Expense
Ratio
Peer
Rank
Global X Longevity Thematic ETF LNGR 20.27 16.92 0.00 0.68 1
iShares US Medical Devices ETF IHI 23.57 24.57 19.45 0.44 2
iShares US Healthcare Providers ETF IHF 14.35 12.62 11.94 0.44 3
ETFis BioShares Biotech Products BBP 12.06 29.91 0.00 0.85 4
Fidelity MSCI Health Care Index ETF FHLC 13.78 10.61 10.93 0.12 5
Vanguard HealthCare Index ETF VHT 13.71 10.69 10.93 0.10 6
Health Care Select Sector SPDR XLV 11.99 8.13 10.33 0.14 7
iShares US Healthcare ETF IYH 12.62 9.39 10.36 0.44 8
iShares Global Healthcare IXJ 15.05 8.41 7.93 0.48 9
iShares Nasdaq Biotechnology IBB 11.57 5.22 6.50 0.47 24
The above table compares the total return performance and expense ratio of iShares Nasdaq Biotechnology to the top rated funds within the Sector - Health/Biotechnology peer group. iShares Nasdaq Biotechnology ranks number 24 out of 35 Sector - Health/Biotechnology closed-end and exchange-traded funds that we rate.

Latest Stock Upgrades/Downgrades